BIO Notebook: FDA User Fees For AI Regulation, Partnering Strategy Evolves, And More

Insights from Day Two of the BIO International Convention in San Diego include the evolving pros and cons of partnering, user fees potentially supporting the FDA's AI ambitions, and J&J's view on dealmaking in 2024.